Literature DB >> 16673289

Immunopathogenesis: role of innate and adaptive immune responses.

Kumar Visvanathan1, Sharon R Lewin.   

Abstract

Hepatitis B virus (HBV) infection in immunocompetent adults usually results in a self-limited, transient liver disease and viral clearance, with only a small percentage (5 to 10%) developing chronic hepatitis associated with viral persistence. In contrast, when neonates are infected, more than 90% become persistently infected, suffering differing degrees of chronic liver disease. Activation of immunity plays a central role in host-virus interactions, greatly influencing viral replication and the clinical outcome of infection. Although all of the specific mechanisms and consequences of this interaction have not been elucidated, the purpose of this article is to describe the basic arms of the immune system as they interact with the HBV and describe the present state of knowledge in this area. These arms may be divided broadly into innate and specific immune responses, and they have different roles and responses in acute and chronic infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16673289     DOI: 10.1055/s-2006-939755

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  13 in total

Review 1.  Hepatitis B virus-induced oncogenesis.

Authors:  Joachim Lupberger; Eberhard Hildt
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

2.  Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.

Authors:  George Boon-Bee Goh; Wan-Cheng Chow; Renwei Wang; Jian-Min Yuan; Woon-Puay Koh
Journal:  Hepatology       Date:  2014-06-24       Impact factor: 17.425

3.  Association of Toll-Like Receptor 3 and Toll-Like Receptor 9 Single Nucleotide Polymorphisms with Hepatitis C Virus Infection and Hepatic Fibrosis in Egyptian Patients.

Authors:  Rania A Zayed; Dalia Omran; Doha A Mokhtar; Zinab Zakaria; Sameera Ezzat; Mohamed A Soliman; Lamiaa Mobarak; Hossam El-Sweesy; Ghada Emam
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

Review 4.  Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19.

Authors:  Caterina Sagnelli; Antonello Sica; Massimiliano Creta; Alessandra Borsetti; Massimo Ciccozzi; Evangelista Sagnelli
Journal:  Pathogens       Date:  2022-05-11

5.  Expression of toll-like receptor 9 in peripheral blood mononuclear cells from patients with different hepatitis B and C viral loads.

Authors:  Jian Zhou; Yuancheng Huang; Deying Tian; Dong Xu; Miao Chen; Huiling Wu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-06-10

6.  Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1''-phosphatase, a viral function conserved in the alpha-like supergroup.

Authors:  Klara Kristin Eriksson; Luisa Cervantes-Barragán; Burkhard Ludewig; Volker Thiel
Journal:  J Virol       Date:  2008-10-15       Impact factor: 5.103

7.  Genetic polymorphisms in the cytokine genes and risk of hepatocellular carcinoma in low-risk non-Asians of USA.

Authors:  Simona Ognjanovic; Jian-Min Yuan; Ann K Chaptman; Yunhua Fan; Mimi C Yu
Journal:  Carcinogenesis       Date:  2009-01-06       Impact factor: 4.944

8.  Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma.

Authors:  Ki Hong Tak; Gyeong Im Yu; Mi Young Lee; Dong Hoon Shin
Journal:  Med Sci Monit       Date:  2018-05-26

9.  CAPIH: a Web interface for comparative analyses and visualization of host-HIV protein-protein interactions.

Authors:  Fan-Kai Lin; Chia-Lin Pan; Jinn-Moon Yang; Trees-Juen Chuang; Feng-Chi Chen
Journal:  BMC Microbiol       Date:  2009-08-12       Impact factor: 3.605

10.  Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.

Authors:  Xiangyang Min; Meng Feng; Yue Guan; Suqin Man; Yongfeng Fu; Xunjia Cheng; Hiroshi Tachibana
Journal:  PLoS Negl Trop Dis       Date:  2016-01-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.